These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 25051126

  • 1. Management of hypercholesterolemia for prevention of atherosclerotic cardiovascular disease: focus on the potential role of recombinant anti-PCSK9 monoclonal antibodies.
    Verma DR, Brinton EA.
    Rev Cardiovasc Med; 2014; 15(2):86-101; quiz 101. PubMed ID: 25051126
    [Abstract] [Full Text] [Related]

  • 2. The potential role of anti-PCSK9 monoclonal antibodies in the management of hypercholesterolemia.
    Lepor NE, Contreras L, Desai C, Kereiakes DJ.
    Rev Cardiovasc Med; 2014; 15(4):290-307; quiz 308-9. PubMed ID: 25662924
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.
    Sullivan D, Olsson AG, Scott R, Kim JB, Xue A, Gebski V, Wasserman SM, Stein EA.
    JAMA; 2012 Dec 19; 308(23):2497-506. PubMed ID: 23128163
    [Abstract] [Full Text] [Related]

  • 8. An update on the clinical development of proprotein convertase subtilisin kexin 9 inhibitors, novel therapeutic agents for lowering low-density lipoprotein cholesterol.
    Ling H, Burns TL, Hilleman DE.
    Cardiovasc Ther; 2014 Apr 19; 32(2):82-8. PubMed ID: 24354905
    [Abstract] [Full Text] [Related]

  • 9. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.
    Agabiti Rosei E, Salvetti M.
    High Blood Press Cardiovasc Prev; 2016 Sep 19; 23(3):217-30. PubMed ID: 27567901
    [Abstract] [Full Text] [Related]

  • 10. PCSK9 antibodies for the treatment of hypercholesterolemia.
    Gouni-Berthold I, Berthold HK.
    Nutrients; 2014 Dec 01; 6(12):5517-33. PubMed ID: 25470376
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficiency and safety of proprotein convertase subtilisin/kexin 9 monoclonal antibody on hypercholesterolemia: a meta-analysis of 20 randomized controlled trials.
    Li C, Lin L, Zhang W, Zhou L, Wang H, Luo X, Luo H, Cai Y, Zeng C.
    J Am Heart Assoc; 2015 Jun 15; 4(6):e001937. PubMed ID: 26077586
    [Abstract] [Full Text] [Related]

  • 16. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: Present perspectives and future horizons.
    Yadav K, Sharma M, Ferdinand KC.
    Nutr Metab Cardiovasc Dis; 2016 Oct 15; 26(10):853-62. PubMed ID: 27352986
    [Abstract] [Full Text] [Related]

  • 17. Design and rationale of the GAUSS-2 study trial: a double-blind, ezetimibe-controlled phase 3 study of the efficacy and tolerability of evolocumab (AMG 145) in subjects with hypercholesterolemia who are intolerant of statin therapy.
    Cho L, Rocco M, Colquhoun D, Sullivan D, Rosenson RS, Dent R, Xue A, Scott R, Wasserman SM, Stroes E.
    Clin Cardiol; 2014 Mar 15; 37(3):131-9. PubMed ID: 24477778
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction.
    Henry CA, Lyon RA, Ling H.
    Vasc Health Risk Manag; 2016 Mar 15; 12():163-9. PubMed ID: 27143910
    [Abstract] [Full Text] [Related]

  • 20. PCSK9 inhibition in patients with hypercholesterolemia.
    Desai NR, Sabatine MS.
    Trends Cardiovasc Med; 2015 Oct 15; 25(7):567-74. PubMed ID: 25771732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.